EcoDrugPlus

Tryptophan Hydroxylase 1

Ensembl ID : ENSRFEG00010020684
Gene Symbol: TPH1
1 Cross references
255 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSRFEG00010010426
Gene Symbol: TUBA1B
1 Cross references
196 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSRFEG00010007280
Gene Symbol: TUBA4A
1 Cross references
224 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSRFEG00010020749
Gene Symbol: TUBB1
1 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSRFEG00010001382
Gene Symbol: TUBB2B
1 Cross references
181 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSRFEG00010011101
Gene Symbol: TUBB3
1 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSRFEG00010014530
Gene Symbol: TUBB4A
1 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSRFEG00010008054
Gene Symbol: TUBB4B
1 Cross references
137 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSRFEG00010010921
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSRFEG00010000368
Gene Symbol: TUBB
1 Cross references
291 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSRFEG00010011010
Gene Symbol: TP53
1 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSRFEG00010015497
Gene Symbol: TYR
1 Cross references
266 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).